O-RADS US v2022 Shows Comparable AUC to v2019 and ADNEX with Higher Specificity

O-RADS ultrasound v2022 had AUC 0.935, sensitivity 98.3%, specificity 70.8% for adnexal mass malignancy (threshold ≥ category 4). Performance comparable to v2019 and ADNEX model, with numerically higher specificity and greater reader agreement.

• O-RADS US v2022 AUC 0.935, sensitivity 98.3%, specificity 70.8% at threshold ≥4.
• AUCs of v2022, v2019, and ADNEX were not significantly different (0.935, 0.919, 0.930).
• v2022 showed higher inter- and intra-reader agreement than v2019.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.